Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma

被引：20

作者：

Sano, Dahlia ^{[1
]}

Nastoupil, Loretta J. ^{[1
]}

Fowler, Nathan H. ^{[2
]}

Fayad, Luis ^{[1
]}

Hagemeister, F. B. ^{[2
]}

Lee, Hun Ju ^{[3
]}

Samaniego, Felipe ^{[3
]}

Wang, Michael ^{[2
]}

Rodriguez, Maria Alma ^{[1
]}

Iyer, Swaminathan P. ^{[2
]}

Parmar, Simrit ^{[3
]}

Steiner, Raphael ^{[2
]}

Nair, Ranjit ^{[1
]}

Adkins, Sherry ^{[1
]}

Arafat, Sara ^{[1
]}

Rao, Ahalya ^{[4
]}

Vallejo, Liliana ^{[1
]}

Hawkins, Misha ^{[1
]}

Chen, Yiming ^{[1
]}

Westin, Jason R. ^{[2
]}

Neelapu, Sattva S. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[4] Md Anderson, Houston, TX USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-120013

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4